Russian chamber of commerce warns of drug shortages due to low pricing

18 July 2017
russia_moscow_large-1-

The Association of the Russian Pharmaceutical Manufacturers (ARPM) has reported on a meeting of the Russian Chamber of Commerce and Industry Committee.

Discussing the development of Russia’s procurement system, attention was called to the risk of drug shortages due to “unprofitable manufacturing of low price segment medicines.”

Viktor Dmitriev, director general of the ARPM, criticised the existing methodology for pricing on vital and essential medicines.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical